## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract
- **Shared manuscript claim summary** The authors report engineering a triple mutant (TIG) of the UvsX recombinase that improves RPA activity at low template concentrations and across a broader temperature range, using a strategy combining energy-based screening, protein language models, and EVOLVEpro. They also report improved expression yield under optimized conditions.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or supplementary data provided.
- **Missing materials affecting confidence** Full manuscript, including methods, figures, tables, supplementary data, and detailed experimental protocols.

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting protein engineering study that addresses a practical limitation of RPA. The combination of computational screening and directed evolution is timely. However, the abstract lacks sufficient quantitative detail and mechanistic evidence to evaluate the robustness of the claims. The reported improvements are modest, and the mechanistic interpretation from MD simulations is not substantiated with specific data. The expression yield claim is also presented without context. The study may be of interest to the synthetic biology and molecular diagnostics communities, but the current abstract does not establish the case convincingly.

- **Who would be interested in the results, and why** Researchers in isothermal amplification, point-of-care diagnostics, and protein engineering. The work addresses a known bottleneck in RPA (UvsX performance at low temperature/template) and proposes a generalizable engineering strategy.

- **Major strengths** 1. Addresses a practically relevant problem (RPA performance at low temperature and low template). 2. Uses a multi-pronged computational-experimental approach (energy-based screening, PLMs, EVOLVEpro). 3. Provides some mechanistic insight via MD simulations.

- **Major Concerns**
    - **Concern ID** R1-M1
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Quantitative evidence
    - **Claim pointer** "TIG achieved 1.89-fold RPA relative activity of the WT at 1×10⁵ copies/reaction, and showed higher amplification activity across 37.5–44.3°C at 1×10⁴ copies/reaction."
    - **Evidence pointer** Abstract; no figure or table provided.
    - **Concern** The abstract reports only a single fold-change value (1.89-fold) and a temperature range. No error bars, replicates, statistical significance, or comparison to other mutants are given. The "higher amplification activity" claim is qualitative.
    - **Why it matters** Without error estimates and statistical testing, the reader cannot assess whether the improvement is reproducible or meaningful. A 1.89-fold increase is modest and may fall within experimental noise.
    - **Resolution test** Provide mean ± SD from at least three independent experiments, with p-values or confidence intervals. Show dose-response curves or endpoint data for multiple template concentrations.

    - **Concern ID** R1-M2
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Mechanistic evidence
    - **Claim pointer** "MD simulations revealed that TIG enhances residue flexibility, remodels the ATP-binding pocket, improves DNA-binding pathway connectivity, and strengthens coupling between ATP hydrolysis and DNA strand exchange."
    - **Evidence pointer** Abstract; no figure or table provided.
    - **Concern** The abstract lists multiple mechanistic claims (flexibility, pocket remodeling, pathway connectivity, coupling) without any quantitative metrics (e.g., RMSF, binding free energies, correlation coefficients). The causal link between these MD observations and the functional improvement is asserted, not demonstrated.
    - **Why it matters** These are strong mechanistic claims that require rigorous validation. Without data, the reader cannot distinguish between genuine insight and overinterpretation of MD trajectories.
    - **Resolution test** Provide key MD metrics (e.g., RMSF plots, binding pocket volume, hydrogen bond occupancy, cross-correlation maps) and show that they correlate with experimental activity. Consider mutational reversions or control simulations.

    - **Concern ID** R1-M3
    - **Severity** Major
    - **Blocking** No
    - **Axis** Expression yield claim
    - **Claim pointer** "Under optimized expression conditions (20°C, 12 h, 0.1 mM IPTG), the yield reached 206.87 ± 3.56 mg/L of TIG."
    - **Evidence pointer** Abstract; no figure or table provided.
    - **Concern** The yield is reported with a small error, but no comparison to WT or other mutants is given. The optimization process is not described. The yield unit (mg/L) is ambiguous (soluble? total? purified?).
    - **Why it matters** Without a baseline (WT yield) and purification details, the improvement cannot be evaluated. The claim is isolated from the functional data.
    - **Resolution test** Report WT yield under the same conditions, specify whether the yield is for soluble or total protein, and describe the purification step.

- **Minor Comments**
    - **Concern ID** R1-m1
    - **Severity** Minor
    - **Axis** Clarity
    - **Affected element** Abstract text
    - **Evidence pointer** Abstract
    - **Issue** "1.89-fold RPA relative activity" is ambiguous: is this fold-change in initial rate, endpoint signal, or something else?
    - **Required correction** Specify the metric (e.g., "1.89-fold increase in endpoint fluorescence" or "1.89-fold higher initial rate").

    - **Concern ID** R1-m2
    - **Severity** Minor
    - **Axis** Completeness
    - **Affected element** Abstract text
    - **Evidence pointer** Abstract
    - **Issue** The temperature range "37.5–44.3°C" is given to one decimal place, but no rationale for these bounds is provided. Is this the full operational range or the range where TIG outperforms WT?
    - **Required correction** Clarify whether this is the range of statistically significant improvement, and state the WT's operational range for comparison.

    - **Concern ID** R1-m3
    - **Severity** Minor
    - **Axis** Terminology
    - **Affected element** Abstract text
    - **Evidence pointer** Abstract
    - **Issue** "Per-residue energy decomposition and protein structure network analyses" are mentioned but not linked to any specific finding.
    - **Required correction** Either remove or briefly state what these analyses revealed (e.g., "identified key residues in the DNA-binding pathway").

- **Technical failings that need to be addressed before the case is established** R1-M1 (quantitative evidence for activity improvement), R1-M2 (mechanistic evidence from MD simulations).

- **Assessment against Nature-style criteria**
    - **Originality**: Moderate. The combination of energy-based screening, PLMs, and EVOLVEpro is not entirely novel, but applying it to UvsX for RPA improvement is a specific contribution.
    - **Scientific importance**: Moderate. Improving RPA performance is practically important, but the reported improvement (1.89-fold) is modest and may not be transformative.
    - **Interdisciplinary readership**: Low to moderate. The work is primarily of interest to protein engineers and molecular diagnostics specialists; the abstract does not frame the broader significance for a general scientific audience.
    - **Technical soundness**: Not assessable from the abstract alone. The claims lack quantitative rigor and mechanistic validation.
    - **Readability for nonspecialists**: Adequate. The abstract is clear but uses jargon (EVOLVEpro, PLMs) without explanation.

- **Recommendation posture** Currently not established from the provided evidence. The abstract raises interesting possibilities but lacks the quantitative and mechanistic detail needed to support the claims. A full manuscript with proper data presentation is required for evaluation.

## Risk / unsupported claims
- The claim that TIG "enhances residue flexibility and remodels the ATP-binding pocket" is unsupported by any quantitative MD data.
- The claim that TIG "improves DNA-binding pathway connectivity and strengthens coupling between ATP hydrolysis and DNA strand exchange" is unsupported.
- The claim that the expression yield of 206.87 mg/L represents an improvement is unsupported without WT comparison.